Regulation of PDL-1 expression in thyroid carcinoma cells by tumor cell derived cytokines activating STAT3.

Autor: Klemke M; Department of Nuclear Medicine, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Excellence Cluster ImmunoSensation, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany., Veit N; Department of Nuclear Medicine, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Excellence Cluster ImmunoSensation, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany., Schmidt-Wolf I; Center for Integrated Oncology (CIO), University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Excellence Cluster ImmunoSensation, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany., Bundschuh RA; Department of Nuclear Medicine, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Excellence Cluster ImmunoSensation, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany., Essler M; Department of Nuclear Medicine, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. Markus.Essler@ukbonn.de.; Excellence Cluster ImmunoSensation, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. Markus.Essler@ukbonn.de., Kreppel B; Department of Nuclear Medicine, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.; Excellence Cluster ImmunoSensation, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

Publikováno v: Immunologic research [Immunol Res] 2024 Dec 19; Vol. 73 (1), pp. 20. Date of Electronic Publication: 2024 Dec 19.

Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.

Autor: Belge G; Department of Tumor Genetics, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany., Dumlupinar C; Department of Tumor Genetics, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany., Nestler T; Department of Urology, Bundeswehrzentralkrankenhaus Koblenz, Koblenz, Germany., Klemke M; Department of Tumor Genetics, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany., Törzsök P; Department of Urology and Andrology, Paracelsus Medical University, Salzburg University Hospital, Salzburg, Austria., Trenti E; Central Hospital Bozen, Department Urology, Bozen, Italy., Pichler R; Department of Urology, University Hospital Innsbruck, Innsbruck, Austria., Loidl W; Ordensklinikum Barmherzige Schwestern, Department Urology, Linz, Austria., Che Y; Department of Urology, Heinrich-Heine-University, Düsseldorf, Germany., Hiester A; Department of Urology, Heinrich-Heine-University, Düsseldorf, Germany., Matthies C; Department of Urology, Bundeswehrkrankenhaus Hamburg, Hamburg, Germany., Pichler M; Research Unit of Non-Coding RNA, Division of Oncology, Medical University of Graz, Graz, Austria., Paffenholz P; Department of Urology, University Hospital Cologne, Cologne, Germany., Kluth L; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Wenzel M; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Sommer J; Department of Urology, St. Franziskus Krankenhaus Lohne, Lohne, Germany., Heinzelbecker J; Saarland University Medical Centre and Saarland University, Department of Urology, Homburg, Germany., Schriefer P; Urologische Gemeinschaftspraxis Buxtehude, Buxtehude, Germany., Winter A; Department of Urology, University Hospital Oldenburg, Oldenburg, Germany., Zengerling F; Department of Urology, Ulm University Hospital, Ulm, Germany., Kramer MW; Department of Urology, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Lengert M; Department of Tumor Genetics, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany., Frey J; miRdetect GmbH, Bremerhaven, Germany., Heidenreich A; Department of Urology, University Hospital Cologne, Cologne, Germany., Wülfing C; Department of Urology, Asklepios Klinik Altona, Hamburg, Germany., Radtke A; miRdetect GmbH, Bremerhaven, Germany., Dieckmann KP; Department of Urology, Asklepios Klinik Altona, Hamburg, Germany.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 17; Vol. 30 (2), pp. 404-412.

A novel flow-cytometry-based assay for quantification of affinity and avidity changes of integrins

Autor: Konstandin, M.H., Sester, U., Klemke, M., Weschenfelder, T., Wabnitz, G.H., Samstag, Y.

Publikováno v: In Journal of Immunological Methods 2006 310(1):67-77

Radiological Assessment of Different Retroperitoneal Lymph Node Measurements in Stage 1 Testicular Cancer Patients: Impact on Clinical Stage and Treatment.

Autor: Strauch, Angelina¹ (AUTHOR), Nestler, Kai² (AUTHOR), Schoch, Justine¹ (AUTHOR), Kubitscheck, Laura² (AUTHOR), Waldeck, Stephan² (AUTHOR), Schmelz, Hans¹ (AUTHOR), Nestler, Tim¹ (AUTHOR) tim-nestler@web.de

Publikováno v: Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 18, p5553. 11p.

Biomarkers of prostate bladder and testicular cancers: current use in anatomic pathology and future directions.

Autor: Morini, Mariana Andozia¹ (AUTHOR), Athanazio, Daniel Abensur^2,3,4 (AUTHOR) dathanazio@gmail.com, Gallas, Luiza Fadul⁵ (AUTHOR), Mota, José Maurício^6,7,8 (AUTHOR), Bezerra, Stephania Martins⁹ (AUTHOR), Lobo, João^10,11,12 (AUTHOR), Froján, María Belén Molina¹³ (AUTHOR), Acosta, Andres¹⁴ (AUTHOR)

Publikováno v: Surgical & Experimental Pathology. 8/20/2024, Vol. 7 Issue 1, p1-31. 31p.